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SYSTEMATIC REVIEW Open Access
The Role of Technology in Adherence to
Physical Activity Programs in Patients with
Chronic Diseases Experiencing Fatigue: a
Systematic Review
Andrea Albergoni1,2, Florentina J. Hettinga3,4, Antonio La Torre1,5, Matteo Bonato5 and Francesco Sartor2,3,6,7*
Abstract
Background: The beneficial role of physical activity (PA) to manage the health condition of patients with chronic
diseases is well known. However, adherence to PA guidelines in this group is still low. Monitoring and user-interface
technology could represent a significant tool to increase exercise adherence to those particular groups who
experience difficulties in adhering to regular and substantial physical activity, and could be supportive in increasing
the success of PA programs and interventions. This systematic review aimed at evaluating the effect of physical
activity monitoring technology in improving adherence to a PA program in patients with chronic diseases
experiencing fatigue.
Methods: This systematic review was conducted according to PRISMA guidelines. The literature search was
performed in Embase, Medline, Biosis, Scopus, and SPORTDiscus. We filtered the literature according to the
question: “Does monitoring technology affect adherence to physical activity and exercise programs in patients with
chronic diseases perceiving fatigue?”.
Results: The search resulted in 1790 hits; finally, eight studies were included, with a total number of 205 patients.
Study quality was moderate except for one study of high quality. Only three disease types emerged, COPD, HF, and
cancer. PA programs were rather short (from 8 to 13 weeks) except for one 3-year-long study. Five studies
employed pedometers and two an activity monitor. Three studies based their adherence on steps, the remaining
studies focused on active minutes. Adherence was explicitly reported in two studies, and otherwise derived. Four
studies showed high adherence levels (85% week-10, 89% week-8, 81% week-13, 105% week-13, 83% average
week-1–12) and three low levels (56% week-12, 41% year-2, 14 year-3).
Conclusion: The small number of studies identified did not allow to establish whether the use of monitoring
technology could improve adherence to PA programs in patients with chronic diseases experiencing fatigue, but
the current evidence seems to suggest that this is a field warranting further study, particularly into how monitoring
technology can help to engage patients to adhere to PA programs.
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Key Points
 Although monitoring technology is a clear emerging
trend in promoting physical activity in patients with
chronic diseases and has potential, hitherto there is
not enough evidence to clarify if the use of
technology supports patients with chronic diseases
to increase exercise adherence.
 Technology is mainly used to monitor physical
activity, but not yet to improve exercise adherence.
In the few studies where this was the case,
adherence levels were high. The role of fatigue
needs to be further researched and the definition of
adherence needs to be standardized.
Background
There is a large body of evidence showing the benefit of
physical activity (PA) and physical exercise for patients
with chronic diseases [1]. The concept “exercise is medi-
cine” as defined by the American College of Sports
Medicine (ACSM), has been widely accepted for the pre-
vention, and in some specific cases, for the treatment of
chronic diseases such as cancer, type 2 diabetes mellitus
(T2DM), cardiovascular diseases [2], and of people with
disabilities [3]. In fact, PA and physical exercise have
been considered a real “polypill” in primary as well as
secondary prevention [4, 5]. Since physical exercise can
be considered a subcategory of PA [1], we will here in-
clude physical exercise in PA. Leisure-time activity, low,
moderate, and vigorous activities have been linked to a
reduction in the risk of T2DM [6], and in inflammatory
markers in breast cancer survivors [7]. In cancer survi-
vors, PA improves quality of life, cardiorespiratory fit-
ness and strength, and it alleviates fatigue [8, 9]. In
chronic obstructive pulmonary disease (COPD) patients,
PA is associated with better respiratory parameters (e.g.,
FEV1, dyspnea) [10]. PA has a strong effect in reducing
atherosclerotic factors, typical of cardiovascular diseases
[11]. Moderate-to-vigorous PA bouts were associated
with lower severity of pain and fatigue in women with
fibromyalgia [12], and graded exercise therapy has
shown benefits for myalgic encephalomyelitis patients
[13]. According to a recent meta-analysis, exercise re-
habilitation improved exercise capacity as well as health-
related quality of life of heart failure patients and it
should be offered to all heart failure patients [14]. In pa-
tients with chronic psychological disorders, PA helps to
increase self-esteem and to reduce depression [15].
Despite the fact that this evidence shows the importance
of PA in preventing and treating patients with chronic dis-
eases, the adherence to guidelines is still rather low. Pa-
tients with a serious mental illness were less active than
the general population [15], only the 9% of them reached
the PA guidelines [16]. Hartman et al. (2010) found that
in Sweden, 84% of COPD, 74% of rheumatoid arthritis,
72% of T2DM and, 60% of healthy individuals did not
adhere to PA guidelines. In a UK cohort of seniors, only
15% of men and 10% of women met guidelines [17] and
dramatically less than 5% of adults in the USA [18].
The term adherence when referring to PA is not always
well defined and uniform. Adherence to a program can be
intended as the number of sessions conducted over the
total number of sessions prescribed, either accounting for,
or regardless whether the sessions were fulfilled or not
[19]. For instance, a patient exercising three times a week,
30 min per session, as prescribed, would have an adher-
ence of 100% as well as a patient training three times a
week but only for 15 min per session, if only the number
of sessions performed were to be accounted for.
The major factors that hinder exercise adherence in pa-
tients with chronic diseases are low self-efficacy, depression,
anxiety, helplessness, poor social support or activity, greater
perceived number of barriers to exercise, and increased
pain levels during exercise [20]. In addition to these, fatigue
in patients with chronic diseases is a common symptom
that decreases adherence to a PA program [21]. In patients
with chronic diseases, fatigue, defined as “a subjective feel-
ing of tiredness, weakness or lack of energy” [22], is re-
ported to be a major obstacle to PA execution [23]. Indeed,
fatigue is an important factor related with low levels of PA
in COPD patients [24]. Fatigue is a typical symptom in can-
cer patients [25] and it persists even after chemotherapy
[9]. Fatigue is also a common symptom in T2DM patients
[26], and PA has been shown to help to manage it [27].
Muscular pain and fatigue make PA intolerable in many
chronic heart failure (HF) patients [28]. Recently, it has
been found that activity pacing, a strategy to divide one’s
daily activities into more manageable portions, might have
sustained beneficial effects on management and reduction
of fatigue in persons with disabilities or chronic diseases as-
sociated with fatigue complaints [29].
In the past years, there has been a large number of strat-
egies aiming at lowering the barriers to engage in PA pro-
grams. It is now common for patients to discuss their PA
habits with their health professionals [30]. Behavioral inter-
ventions such as motivational interviewing and goal-setting
are commonly used [31]. Furthermore, large-scale strat-
egies, such as national walking programs, have been also
deployed to increase PA in the entire population [32]. Re-
cently, programs also started targeting persons with disabil-
ities and chronic diseases for example in the ReSpAct study
in the Netherlands [33]. Finally, health professional supervi-
sion by itself can increase adherence, and monitoring is its
key element [34].
Electronic devices can be adopted to monitor adherence
as long as they are used in a systematic manner [34].
However, there is a large gap between self-reported PA
and measured PA [35] as self-reported PA is known to be
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not always reliable. For this reason, PA programs better be
implemented with the use of human interface and moni-
toring technology such as web sites [30, 32, 36], mobile
devices [37], apps [38], and wearable devices [39]. Add-
itionally, the presence of an objective goal (daily steps or
exercise minutes) can be a key-factor to successfully in-
crease PA, without it the improvements may be limited or
even absent [40]. Wearable technology was identified as
the leading fitness trend in 2019 [41]. Indeed, ACSM-cer-
tified professionals identified it as a tool to positively
change PA behavior [41]. Activity and exercise metrics
such as step counts, distance covered, active or walking
time can be tracked by pedometers, in addition, more re-
cently, energy expenditure, activity types, and intensity
can be monitored by accelerometer and heart rate sensors
implemented on wearables or, in some cases, on smart-
phones. Nowadays, also global positioning systems are
often used for physical and exercise activity tracking [42].
The added value of technology is not confined to monitor-
ing patients’ PA objectively, but it extends to patients’
stimulation and engagement to increase adherence [43].
For instance, human interface technology can reduce the
gap between therapists and patients, who may feel more
responsible to adhere when directly supervised [44]. Fur-
thermore, technology tools offer the possibility for a more
enjoyable and motivational approach to PA programs
(e.g., exergaming) [44, 45]. Taken together, this evidence
suggests the high potential of the monitoring and user-
interface technology in promoting an active lifestyle in
persons with disabilities and chronic diseases.
The aim of this systematic review was to evaluate
whether in patients with chronic diseases experiencing
fatigue the use of monitoring technology would improve
adherence to a PA program in the mHealth and eHealth
space such as a home and/or rehabilitation settings.
Methods
This systematic review was conducted following PRISMA’s
guidelines [46], and it was registered in the Prospero Data-
base (CRD42018109081). The research question for this
systematic review was: “Does monitoring technology affect
adherence to physical activity and exercise programs in pa-
tients with chronic diseases perceiving fatigue?”. Studies
published in English from the year 2006 were included in
the search. We did not exclude conference abstracts and re-
quested full-texts when they were not available. We col-
lected studies from Embase, Medline, and Biosis on the
19th of March 2018, using this keywords (((((((physical n1
activ* OR function*) n10 program*) OR (activity n2 pacing)
OR rehabilitation) AND (adhere OR motiv* OR complai-
n*))AND (pedometer* OR accelerometer* OR monitor* OR
wearable* OR watch* OR phone* OR band* OR heart rate*
OR monitor* OR telemonitor* OR mhealth* OR ehealth*
OR telehealth*)) AND ((chronic* n5 disease* OR ill*) OR
copd OR fatigue OR diabetes OR heart failure OR cancer
OR malignant neoplasm OR osteoarthritis OR rheumatoid
arthritis OR fibromyalgia OR cancer fatigue OR chronic fa-
tigue syndrome)))). An additional search in the same data-
bases was executed on the 23rd of March 2018 adding
“cancer” to the previous search. The search was executed
using Scientific & Technical Information Network library;
additionally, three more searches were conducted with the
same key words in the same database as mentioned above
with the inclusion of Scopus, and SPORTDiscus the 30th of
April 2019.
In order to be included, the studies had to satisfy the
following criteria: Was this study conducted in a clinical
population experiencing fatigue? Was monitoring tech-
nology used? Did this study concern activity/exercise
programs? Was adherence calculated or derivable from
this study? Was monitoring technology used to improve
adherence? The use of monitoring technology in im-
proving adherence referred to continuous and long at
least one month period. Studies in which monitoring
technology was used, but not to provide any feedback,
were excluded. For instance, studies in which partici-
pants were blinded to pedometers or accelerometers
output were not included. Full text screening was con-
ducted by two independent researchers (A.A. and F.S.).
Adherence was generally defined as PA performed
over the total PA target prescribed times 100. If adher-
ence was not directly available, we calculated it.
Quality was assessed according to the Downs and
Black checklist [47] cited in the Cochrane’s Handbook
for Systematic Reviews of Interventions (see Table 1)
[48]. We assigned a score of 1 in case of a positive an-
swer, 0 when negative or unknown. Studies with a total
score from 11 to 15 were considered “high quality”, 6–
10 “medium quality”, 0–5 “low quality.” Two studies
scored high quality [49, 50], the other studies were clas-
sified as medium quality (Table 2).
Results
The study search process is presented in the Fig. 1. The
search identified 1790 records, 1674 after removing du-
plicates. During the process of study selection and data
analysis, eight more studies were identified through ref-
erence lists as possibly interesting and included. From
records screened, we selected 312 abstracts. A total of
85 full-text manuscripts were reviewed. In the end, eight
studies were selected based on our inclusion criteria and
included in this systematic review. Two studies referred
to the same data collection [44, 50]. Main outcomes of
included studies are summarized in Table 3.
Patient Groups
This systematic review includes eight studies, comprising
195 patients, 89 COPD [41, 45, 46, 48, 51], 39 cancer
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patients [51], 43 cancer survivors [55], and 24 patients
with HF [53]. Mendoza et al. recruited COPD patients
with both I, II, III, and IV GOLD 2011 [56] classification
[49]. The same patients had no (n = 8), slight (n = 22),
moderate (n = 14), and severe (n = 8) dyspnea and none
had very severe dyspnea, assessed with the Modified
Medical Research Council (MMRC) dyspnea scale [49].
Patients with other chronic conditions were excluded
[49]. Moy et al. recruited patients with no (n = 4), slight
(n = 10), moderate (n = 6), severe (n = 4), and very se-
vere (n = 1) dyspnea assessed with the MMRC scale
[54]. Benzo et al. recruited patients with II, III, and IV
COPD GOLD 2011 [56] stage [52]. The description of
the ten COPD patients undergoing 2 years intervention
Table 1 Quality assessment questions
1 Is the hypothesis/aim/objective of the study clearly described?
2 Are the characteristics of the patients included in the study clearly described?
3 Are the main findings of the study clearly described?
4 Does the study provide estimates of random variability in the data for the main outcomes (e.g., interquartile range for non-normally distributed
data; standard error, standard deviation, or confidence intervals for normally distributed data)?
5 Have the actual probability values been reported (e.g., .035 rather than < .05) for the main outcomes except where the probability value is less
than .001?
6 Were those subjects who were prepared to participate representative of the entire population from which they were recruited?
7 Were the staff, places, and facilities where patients were treated representative of the treatment the majority of patients receive? Was PA in line
with guidelines or a program ad-hoc? Internal validity
8 Were the main outcome measures used accurate (Is the device valuated and reliable)?
9 Was this study a clinical trial?
10 Was it randomized?
11 Was it blind?
12 Did the adherence have a direct output (e.g., it did not need to be derived)?
13 Was the output of the monitor in line with guidelines?
14 Was the duration of study in line with guidelines?
15 Was there a follow-up?
Table 2 Quality assessment and risk of bias
Study
question
Backman et al.
[51]
Benzo et al.
[52]
Gary et al.
[53]
Hoaas et al.
[44]
Hoaas et al.
[50]
Mendoza et al.
[49]
Moy et al
[54]
Pinto et al.
[55]
1 1 1 1 1 1 1 1 1
2 1 0 1 0 1 1 1 1
3 1 1 1 1 1 1 1 1
4 0 0 1 0 1 1 1 1
5 0 0 1 0 1 1 1 1
6 0 0 0 0 0 0 0 0
7 0 0 0 0 0 0 0 0
8 1 1 0 0 1 1 1 1
9 0 1 0 1 1 1 1 0
10 1 0 1 0 0 1 0 1
11 0 0 0 0 0 1 0 0
12 1 1 1 1 1 0 0 1
13 1 1 1 1 1 1 1 1
14 0 0 1 1 1 1 0 1
15 0 0 1 1 1 0 0 0
Total 7 6 10 7 11 11 8 10
Score Medium Medium Medium Medium High High Medium Medium
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and one additional year of unsupervised follow-up [44, 50]
is presented in Zanaboni et al. [57], showing that the ma-
jority of them had high COPD assessment test (CAT)
scores (n = 6), and the rest medium (n = 3) or low (n = 1)
CAT scores. Backman el al. recruited patients with breast
and colorectal cancer (CRC), all of whom undergoing
chemotherapy treatment [51]. Pinto et al. recruited 43
breast cancer survivors, with cancer at stage 0 (n = 8), 1 (n =
17), and 2 (n = 18); 55.8% of them received chemotherapy
[55]. Gray et al. selected patients with stable systolic HF,
with slight and marked limitation to PA, class II and III of
the New York Association (NYHA) classification [53].
Program Characteristics
In three studies, PA programs were based on step counts
[49, 51, 54]; in other studies, the goal was expressed in
minutes of activity [44, 50, 52, 53, 55]. PA programs
were personalized and activity levels adjusted in four
studies [49, 53–55], with the final goal to meet the
guidelines formulated in the different studies. Hoaas et
al. prescribed a home-based interval training based on
heart rate, 4 × 4 min of intense walking, three times per
week [44, 50]. Backman et al. proposed 10,000 steps per
day as a fixed goal [51]. Benzo et al. used 12 min of slow
walking in a COPD home-based rehabilitation program,
6 days/week [52]. In Backman et al., PA increased in the
intervention group compared with the control group,
but decreased during the study [51]. Benzo et al. did not
analyze PA as pre-post intervention [52]. Programs
lasted a minimum of 8 weeks to a maximum of 2 years.
Monitoring Technology Characteristics
Pedometers were the prevalent type of monitoring tech-
nology used [49, 51, 54, 55]; other studies used activity
monitors [52], pulse oximeters [44, 50], and heart moni-
tors [53]. For seven out of eight studies, it was possible
Fig. 1 Selection process of studies
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to determine the type of sensing technology used. The
sensors were a 2-axial [53] and 3-axial accelerometer
[49], a pair of piezoelectric sensors oriented at 90° [54],
either a spring-levered or a piezo-electric pedometer
[55], and finally an unspecified accelerometer [52]. The
patients could check the last 7 days steps in all four pe-
dometers, which kept around 30–40 days in memory.
The activity monitor could store up to 21 days. Hoaas et
al. [44] used a portable finger pulse oximeter (Nonin
GO2 LED) to measure SPO2 and heart rate during exer-
cise. This device does not have memory, thus patients
were asked to write down their maximal HR, that they
observed during every exercise session [57]. In Gary et
al. in addition to the pedometer, a heart rate chest strap
(Polar) was used [53]. Two devices had USB connection
[51, 54], Vivofit 2 used in Benzo et al. had Bluetooth con-
nectivity [52]; the DigiWalker, Omron HJ-112, the Tanita
PD-724, and the Nonin GO2 LED did not seem to have
any type of digital connectivity [49, 53, 55, 57]. Battery life
ranged from 6 months to 1 year. All devices seemed to
have a rather reasonable price, not exceeding £60 per unit
(£24 to £58). Except for Hoaas et al. [44, 50] in which a
£80 pulse oximeter, a £400 tablet, and a £600 treadmill
were used per patient, making it up to a total of £1085 per
patient in equipment cost only [57]. Two studies imple-
mented PA monitoring on a website connected to the pe-
dometers [52, 54]. PA monitoring was continuous for all
studies.
Monitoring Technology Usability
In Mendoza et al. and Backman et al., step counts mea-
sured by pedometers were manually reported in daily
diaries [40, 52]. In contrast, in Benzo et al. and Moy et
al., devices (i.e., pedometers and activity monitor arm-
bands) were connected directly to an internet-supported
digital system, so that patients could monitor their pro-
gress online [42, 53]. In Hoaas et al. [44, 50], videoconfer-
ences were used to remotely supervise training sessions, as
the tablet was fixed onto the treadmill [57], during this
conferences HR values were reported. In Gary et al. [53],
the HF patients kept training session logs, and these were
weekly reviewed by a nurse or an exercise specialist. Pa-
tients received monthly, or weekly, motivational support,
in the form of calls, messages on a personal webpage, or
e-mails in every study [44, 49–53, 55]. Motivational mes-
sages were shown to help patients increase their PA levels
[58]. Benzo et al. and Backman et al. provided their pa-
tients with a fixed goal [51, 52]. Instead, in other three
studies, the researchers gave periodical goals. Mendoza et
al. set goals during weekly calls [52], Pinto et al. during
monthly appointments [54], and Moy et al. delivered the
first goal by e-mail; afterwards, patients could check their
weekly goals directly from the website [53]. Hoaas et al.’s
[44, 57] goals were set by using the rating of perceived
exertion scale and the participants were motivated via vid-
eoconferencing [57].
Mendoza et al., Moy el al., and Pinto et al. provided
personalized goals [52–54]. In these studies, patients’ PA
increased. In fact, only Backman et al. did not report a
PA increase; probably due to patients’ sufficiently active
baseline levels (9000 steps/day) [40]. Only in Pinto et al.
and Gary et al., the program was prescribed using heart
rate monitoring to individualize moderate PA [53]. Goals
in Gary et al. [53] were based on HR and RPE and pro-
gressively increased from 50 to 70% of their maximum.
Mendoza et al. considered pedometers user-friendly and
reported experience of pedometer usability [52]. Conversely,
Backman et al. observed that their patients experienced diffi-
culties to manually record steps in activity diaries [40]. Moy
et al. reported some problems in using pedometers and a
website [53]. The main two problems were pedometer wear-
ability at the waist, and first step counts upload; nonetheless,
these difficulties were resolved in time.
Fatigue
Of the selected studies, only Backman et al. quantified fa-
tigue, assessed by means of the European Organization for
Research and Treatment of Cancer quality of Life Ques-
tionnaire (EORTC QLQ-C30) [51]. Fatigue did not signifi-
cantly increase during the intervention in this study and
no differences were found compared to control group
[51]. Although the other studies did not directly quantify
fatigue, the patient populations investigated are known to
suffer from fatigue, which exacerbates during exercise. Fa-
tigue is in fact well characterized in all diseases included
in this systematic review [59–62].
Adherence Outcomes
Only two studies reported adherence as percentage of the
total goal [51, 55]. Three reported it as the participation to
PA session out of the total recommendation [44, 50, 53].
In the other studies, we derived adherence as follows.
Mendoza et al. [49] provided us the data to calculate ad-
herence. Then, we applied a one-way analysis of variance
(ANOVA) for repeated measures to evaluate adherence
values of the intervention group over time. Adherence
values did not statistically differ. In the remaining studies
[52, 54], adherence was calculated by us as a ratio between
the executed PA and the PA goal (for details see adher-
ence column Table 3).
Discussion
The purpose of this systematic review was to evaluate
the potential of using monitoring technology to improve
adherence to a PA program, for patients with chronic
diseases experiencing fatigue complaints. When looking
at qualitative evidence provided by this systematic re-
view, we concluded that it was not possible to establish
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whether the use of monitoring technology was able to
positively influence physical activity adherence in pa-
tients with chronic diseases experiencing fatigue.
From 1790 hits, we included only eight studies. We se-
lected the studies in which monitoring technology was used
by patients to control their PA level and their progress and
by doing so this would potentially improve program adher-
ence. When defining the effect of monitoring technology to
improve physical activity adherence, we included any
technological tools which provided direct feedback to users
(e.g., progress, achievements), as such able to increase their
awareness and/or engagement, ultimately possibly resulting
in a greater program adherence. We included only studies
with patients with chronic diseases to whom fatigue could
represent a serious obstacle to being active.
Monitoring Technology Tools
The results underline that pedometers are the most used
monitoring technology tools in the clinical context. The
studies included in our systematic review seem to con-
firm that pedometers help to increase PA [63]. Unfortu-
nately, an increase in PA was not always followed by
health outcome improvements [40]. Although defining a
PA program goal in steps is straightforward for most pa-
tients, this may in some cases not elicit a clear increase
in their cardiorespiratory fitness. Moreover, half of the
participants who reached a 10,000 steps target did not
meet the minimum goal of 30 min of daily activity (in
10-min bouts) [64]. Programs that prescribed exercise
intensity improved cardiorespiratory fitness more than
programs prescribing only quantity of exercise (e.g.,
steps) [65]. Despite some difficulties, it could be inferred
that the use of wearable devices, such as pedometers, is
convenient and user-friendly for patients with chronic
diseases even when they are elderly. However, it needs
to be acknowledged that the accuracy of step counting
at lower speeds has been found to be reduced [66, 67].
The only long-term adherence intervention study had,
however, a small sample size (n = 10), and it did show a
drastic decrease in adherence when the training sessions
were no longer remotely supervised [44, 50]. This sys-
tematic review seems to point toward the idea that moni-
toring technology can help to reduce the gap between
patients and therapists. Furthermore, it confirms the im-
portance, and often the necessity, of maintaining a personal
relationship through calls or personalized motivational
messages. If these messages are impersonal and automated,
this can lead to a lower efficacy [68].
Drop-Outs and Fatigue
In Mendoza et al., drop-out rate was 4.9% (5 COPD pa-
tients, three in the intervention group and two in the con-
trol group). No specific causes were reported. Moy et al.
described that three COPD patients did not complete the
study (11%), reporting medical problems. Further, two pa-
tients were excluded from data analysis for incomplete
step uploading, and interruptions due to medical prob-
lems [54]. Pinto et al. included the low rate of attrition
(5%) as one of the strengths of their study [55]. In Back-
man et al., 26% of the cancer patients dropped-out, be-
cause of personal reasons, stress, treatments side effects,
and fatigue [51]. For these patients, stress during treat-
ment, health reasons, and fatigue constituted the barriers
to nonparticipation. Despite the burdensome treatments,
cancer patients showed a good or optimum PA level at
the end of the interventions (≃ 8500 and 14,500 steps/day)
[51, 55]. Indeed often, cancer patients did not have prob-
lems to complete PA interventions [69]. No dropouts were
recorded by Gary et al. [53] during the intervention (n =
24) in HF patients. However, the screening of 615 poten-
tial participants led to a 75% rejection rate (documented
non-adherence to medication was one of the exclusion
criteria), and of the 25% finally invited only 4% responded
to the invitation, enrolling a well-selected sample. Only
one of the ten COPD patients in the study of Hoaas et al.
[44, 50] dropped out during the 3-year study period.
An important selection criterion for this systematic re-
view was the presence of fatigue suffered by the patients
with chronic diseases undergoing a PA program. Al-
though fatigue was known to be present in all eight
studies selected, only Backman et al. assessed fatigue dir-
ectly [51]. Fatigue was one of most relevant symptoms
both for the intervention and the control group. Fatigue
did not change during the study, yet according to Back-
man et al., it could be a possible cause of decrement in
adherence [51].
PA levels of COPD patients were lower compared to
cancer patients, yet the age of the COPD patients was
higher compared to the other studies included in this sys-
tematic review and COPD conditions were moderate. This
systematic review confirmed also that walking is the most
common and feasible way to approach physical activity for
patients with chronic diseases; in particular for cancer pa-
tients [69]. Only in Backman et al., colorectal cancer pa-
tients reported barriers to walking, as their therapy’s
complications included hand-foot syndrome [51].
Self-Efficacy and Intervention Duration
The importance of self-efficacy of patients with chronic
diseases in carrying out a PA program is known [70]. In
fact, Pinto et al. showed how self-efficacy values repre-
sent a predictor of goal achievement [55]. Interestingly,
Moy et al. looked at self-efficacy at the beginning and at
the end of the study and found no changes, whereas PA
level increased [54]. Also in Hoaas et al. [44, 50], self-ef-
ficacy did not change from 2 to 3 years, while adherence
dropped drastically. Backman et al. underlined how the
length of the intervention influences adherence to a PA
Albergoni et al. Sports Medicine - Open            (2019) 5:41 Page 8 of 11
program; the longer the study, the lower the adherence
[51]. Yet, Hoaas et al. outcomes seemed to suggest that
cessation of remote supervision of training sessions was
the underlying cause of the drop in adherence. The
mean duration of the interventions considered in these
studies was 32 weeks, ranging from 8 to 156 weeks.
Clinical Outcomes
Backman et al. showed that cancer patients with a 10,000
steps goal for 10 weeks and adherence levels of 85%, de-
creased body weight without a change in body compos-
ition and decreased blood pressure, but did not show
changes in inflammatory markers. Moreover, those cancer
patients reported a decrease in symptoms but no alter-
ations in QoL [51]. Moy et al. observed that COPD pa-
tients, undergoing 13 weeks personalized PA program
with a very high adherence, did not change their general
health status (measured with Medical Study Short Form-
36 questionnaire) and neither their dyspnea [54]. Con-
versely, Mendoza et al. [49] with a similar program in
similar patients as Moy et al. [54], but lower adherence,
found changes in the health status (SGRQ and CAT) but
not in dyspnea (MMRC). Yet in Mendoza et al. [49], abso-
lute step counts were higher than in Moy et al. [54] (from
4000 to 7000 steps circa). Gary et al. [53] found a large in-
crease in QoL (i.e., 23 point on the Minnesota Living With
Heart Failure Questionnaire) in the intervention group,
which had 83% adherence, versus no change in the control
group. Hoaas et al. [44, 50] did not observe significant
clinical changes in 2 years intervention but adherence
after the first year was already below 50%. Benzo et al. and
Pinto et al. did not report clinical outcomes and/or health
status parameters [52, 55].
Limitations
This systematic review has several limitations. One of the
main limitations is the lack of adherence measurements
the included literature analyzed. Moreover, there is poor
consistency on what the term adherence really means
when referring to PA programs. Pinto et al. and Backman
et al. considered adherence both as continuous (minutes
of exercise) and dichotomous (if participants met their
goal) outcomes [51, 55]. Benzo et al., Gary et al., and
Hoaas et al., reported adherence as a percentage of num-
ber of sessions performed, assuming that each daily ses-
sion begun was completed [44, 50, 52]. The other two did
not define adherence, which was calculated by us as the
weekly mean of daily scores expressed as a percentage of
the daily goal.
The low number of studies, the small sample size, the
overall short duration of interventions (max 13 weeks),
with the exception of one study, and the low heterogen-
eity of chronic disease types (only COPD, HF, and can-
cer patients) represent further limitations. At the same
time, these limitations identify gaps in current literature
regarding using wearable technology to stimulate an ac-
tive lifestyle in special populations, based on which rec-
ommendations for future research directions can be
determined. Finally, although this systematic review fo-
cused on patients with chronic diseases experiencing fa-
tigue, fatigue was explicitly measured only in one study
of the eight included. We have selected studies where,
based on the literature, it was safe to assume the pres-
ence of fatigue complaints.
Conclusions
The small body of evidence found in this systematic re-
view does not allow us to establish whether the use of
wearable technology was able to improve adherence to PA
programs in patients with chronic diseases experiencing
fatigue. The eight studies finally selected were of medium-
high quality but with small sample sizes and including
only three types of chronic diseases. In general, the studies
analyzed in this systematic review showed high levels of
adherence associated with monitoring technology, yet for
rather short PA programs (max 13 weeks). Indeed the lon-
gest study taken into account, 2 years intervention plus 1
year follow-up showed a drop in adherence from 70% at
the end of year 1 down to 40% at the end of year 2 [44].
Furthermore, in these studies, there did not seem to al-
ways be a strong relation between high adherence to PA
programs and positive clinical health outcomes. This re-
view has also underlined the necessity to clarify and
standardize the definition of adherence. Six out of eight
studies used very similar monitoring technology, predom-
inantly pedometers, and all were worn at the waist. The
adoption of mobile applications to monitor adherence in
this population was still absent. Although these patients
with chronic diseases experienced fatigue, this did not
seem to influence adherence levels. Technology was
mainly used to objectively monitor PA, rather than to im-
prove adherence. Yet, the use of monitoring technology to
improve fitness and wellbeing is a clear trend and may po-
tentially be particularly useful as assistive tool to stimulate
an active lifestyle and exercise adherence in special popu-
lations. Future research should investigate whether moni-
toring technology is effective in improving PA adherence,
and if so, how effective it is and what the best implemen-
tation would be.
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